Coperion K-Tron, Hosokawa and Sly Inc. Offer Milling and Material Handling Seminar - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Coperion K-Tron, Hosokawa and Sly Inc. Offer Milling and Material Handling Seminar


Coperion K-Tron, together with Hosokawa Powder Micron Systems and Sly, Inc., are hosting a complimentary, in-house demonstration on milling and material handling for pharmaceutical and and other applications on Oct. 14-15 at Hosokawa’s Summit, NJ facility.

Coperion K-Tron is presenting on key topics and trends related to ingredient feeding and material handling, offering a technical objective overview on methods of both improving current operations and utilizing new process technologies in feeding and sanitary pneumatic conveying of powder and bulk materials. The seminar gives guests the opportunity to participate in live milling demonstrations and hands-on access to ancillary equipment including Coperion K-Tron’s new MT12/MT16 Micro-ingredient Feeder.

The seminar is suitable for process engineers and equipment operators interested in air classifying mills, ingredient feeders, granulators, hammer mills, sanitary pneumatic conveying, pin mills, or dust collection systems.

Source: Sly Inc.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
30%
Oversee medical treatment of patients in the US.
9%
Provide treatment for patients globally.
8%
All of the above.
45%
No government involvement in patient treatment or drug development.
8%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics

Click here